nodes	percent_of_prediction	percent_of_DWPC	metapath
Verteporfin—Back pain—Thiotepa—sarcoma	0.00396	0.00396	CcSEcCtD
Verteporfin—Inflammation—Epirubicin—sarcoma	0.00388	0.00388	CcSEcCtD
Verteporfin—Cardiac disorder—Vincristine—sarcoma	0.00387	0.00387	CcSEcCtD
Verteporfin—Vision blurred—Thiotepa—sarcoma	0.00385	0.00385	CcSEcCtD
Verteporfin—Arthropathy—Doxorubicin—sarcoma	0.00383	0.00383	CcSEcCtD
Verteporfin—Musculoskeletal pain—Epirubicin—sarcoma	0.00381	0.00381	CcSEcCtD
Verteporfin—Pneumonia—Etoposide—sarcoma	0.00378	0.00378	CcSEcCtD
Verteporfin—Anaemia—Thiotepa—sarcoma	0.00378	0.00378	CcSEcCtD
Verteporfin—Angiopathy—Vincristine—sarcoma	0.00378	0.00378	CcSEcCtD
Verteporfin—Ill-defined disorder—Dactinomycin—sarcoma	0.00377	0.00377	CcSEcCtD
Verteporfin—Anaemia—Dactinomycin—sarcoma	0.00375	0.00375	CcSEcCtD
Verteporfin—Injection site reaction—Epirubicin—sarcoma	0.00374	0.00374	CcSEcCtD
Verteporfin—Acute coronary syndrome—Etoposide—sarcoma	0.00371	0.00371	CcSEcCtD
Verteporfin—Myocardial infarction—Etoposide—sarcoma	0.00368	0.00368	CcSEcCtD
Verteporfin—Creatinine increased—Doxorubicin—sarcoma	0.00366	0.00366	CcSEcCtD
Verteporfin—Malaise—Dactinomycin—sarcoma	0.00366	0.00366	CcSEcCtD
Verteporfin—Inflammation—Doxorubicin—sarcoma	0.00359	0.00359	CcSEcCtD
Verteporfin—Cough—Thiotepa—sarcoma	0.00357	0.00357	CcSEcCtD
Verteporfin—Hypertension—Thiotepa—sarcoma	0.00353	0.00353	CcSEcCtD
Verteporfin—Musculoskeletal pain—Doxorubicin—sarcoma	0.00353	0.00353	CcSEcCtD
Verteporfin—Back pain—Vincristine—sarcoma	0.00351	0.00351	CcSEcCtD
Verteporfin—Arthralgia—Thiotepa—sarcoma	0.00348	0.00348	CcSEcCtD
Verteporfin—Dry eye—Epirubicin—sarcoma	0.00348	0.00348	CcSEcCtD
Verteporfin—Injection site reaction—Doxorubicin—sarcoma	0.00346	0.00346	CcSEcCtD
Verteporfin—Unspecified disorder of skin and subcutaneous tissue—Thiotepa—sarcoma	0.00346	0.00346	CcSEcCtD
Verteporfin—Back pain—Mitoxantrone—sarcoma	0.00342	0.00342	CcSEcCtD
Verteporfin—Discomfort—Dactinomycin—sarcoma	0.00341	0.00341	CcSEcCtD
Verteporfin—Hypoaesthesia—Etoposide—sarcoma	0.00336	0.00336	CcSEcCtD
Verteporfin—Anaemia—Vincristine—sarcoma	0.00335	0.00335	CcSEcCtD
Verteporfin—Vision blurred—Mitoxantrone—sarcoma	0.00333	0.00333	CcSEcCtD
Verteporfin—Oedema—Dactinomycin—sarcoma	0.00331	0.00331	CcSEcCtD
Verteporfin—Ill-defined disorder—Mitoxantrone—sarcoma	0.00328	0.00328	CcSEcCtD
Verteporfin—Nervous system disorder—Thiotepa—sarcoma	0.00327	0.00327	CcSEcCtD
Verteporfin—Anaemia—Mitoxantrone—sarcoma	0.00326	0.00326	CcSEcCtD
Verteporfin—Vertigo—Vincristine—sarcoma	0.00326	0.00326	CcSEcCtD
Verteporfin—Skin disorder—Thiotepa—sarcoma	0.00324	0.00324	CcSEcCtD
Verteporfin—Dry eye—Doxorubicin—sarcoma	0.00322	0.00322	CcSEcCtD
Verteporfin—Malaise—Mitoxantrone—sarcoma	0.00318	0.00318	CcSEcCtD
Verteporfin—Eye disorder—Etoposide—sarcoma	0.00315	0.00315	CcSEcCtD
Verteporfin—Flushing—Etoposide—sarcoma	0.00313	0.00313	CcSEcCtD
Verteporfin—Cardiac disorder—Etoposide—sarcoma	0.00313	0.00313	CcSEcCtD
Verteporfin—Hypertension—Vincristine—sarcoma	0.00313	0.00313	CcSEcCtD
Verteporfin—Photosensitivity—Epirubicin—sarcoma	0.00311	0.00311	CcSEcCtD
Verteporfin—Cough—Mitoxantrone—sarcoma	0.00308	0.00308	CcSEcCtD
Verteporfin—Angiopathy—Etoposide—sarcoma	0.00306	0.00306	CcSEcCtD
Verteporfin—Hypertension—Mitoxantrone—sarcoma	0.00305	0.00305	CcSEcCtD
Verteporfin—Immune system disorder—Etoposide—sarcoma	0.00305	0.00305	CcSEcCtD
Verteporfin—Eczema—Epirubicin—sarcoma	0.00304	0.00304	CcSEcCtD
Verteporfin—Musculoskeletal discomfort—Thiotepa—sarcoma	0.00304	0.00304	CcSEcCtD
Verteporfin—Musculoskeletal discomfort—Dactinomycin—sarcoma	0.00302	0.00302	CcSEcCtD
Verteporfin—Arthralgia—Mitoxantrone—sarcoma	0.00301	0.00301	CcSEcCtD
Verteporfin—Chest pain—Mitoxantrone—sarcoma	0.00301	0.00301	CcSEcCtD
Verteporfin—Discomfort—Mitoxantrone—sarcoma	0.00297	0.00297	CcSEcCtD
Verteporfin—Oedema—Vincristine—sarcoma	0.00296	0.00296	CcSEcCtD
Verteporfin—Nervous system disorder—Vincristine—sarcoma	0.0029	0.0029	CcSEcCtD
Verteporfin—Oedema—Mitoxantrone—sarcoma	0.00288	0.00288	CcSEcCtD
Verteporfin—Gastrointestinal disorder—Thiotepa—sarcoma	0.00288	0.00288	CcSEcCtD
Verteporfin—Photosensitivity—Doxorubicin—sarcoma	0.00288	0.00288	CcSEcCtD
Verteporfin—Hyperhidrosis—Vincristine—sarcoma	0.00286	0.00286	CcSEcCtD
Verteporfin—Dermatitis bullous—Epirubicin—sarcoma	0.00286	0.00286	CcSEcCtD
Verteporfin—Pain—Thiotepa—sarcoma	0.00285	0.00285	CcSEcCtD
Verteporfin—Constipation—Thiotepa—sarcoma	0.00285	0.00285	CcSEcCtD
Verteporfin—Back pain—Etoposide—sarcoma	0.00284	0.00284	CcSEcCtD
Verteporfin—Shock—Mitoxantrone—sarcoma	0.00284	0.00284	CcSEcCtD
Verteporfin—Pain—Dactinomycin—sarcoma	0.00283	0.00283	CcSEcCtD
Verteporfin—Eczema—Doxorubicin—sarcoma	0.00281	0.00281	CcSEcCtD
Verteporfin—Skin disorder—Mitoxantrone—sarcoma	0.0028	0.0028	CcSEcCtD
Verteporfin—Hyperhidrosis—Mitoxantrone—sarcoma	0.00279	0.00279	CcSEcCtD
Verteporfin—Feeling abnormal—Thiotepa—sarcoma	0.00275	0.00275	CcSEcCtD
Verteporfin—Diplopia—Epirubicin—sarcoma	0.00273	0.00273	CcSEcCtD
Verteporfin—Osteoarthritis—Epirubicin—sarcoma	0.00273	0.00273	CcSEcCtD
Verteporfin—Feeling abnormal—Dactinomycin—sarcoma	0.00273	0.00273	CcSEcCtD
Verteporfin—Ill-defined disorder—Etoposide—sarcoma	0.00273	0.00273	CcSEcCtD
Verteporfin—Anaemia—Etoposide—sarcoma	0.00271	0.00271	CcSEcCtD
Verteporfin—Musculoskeletal discomfort—Vincristine—sarcoma	0.0027	0.0027	CcSEcCtD
Verteporfin—Urticaria—Thiotepa—sarcoma	0.00265	0.00265	CcSEcCtD
Verteporfin—Malaise—Etoposide—sarcoma	0.00265	0.00265	CcSEcCtD
Verteporfin—Dermatitis bullous—Doxorubicin—sarcoma	0.00265	0.00265	CcSEcCtD
Verteporfin—Vertigo—Etoposide—sarcoma	0.00264	0.00264	CcSEcCtD
Verteporfin—Body temperature increased—Thiotepa—sarcoma	0.00264	0.00264	CcSEcCtD
Verteporfin—Musculoskeletal discomfort—Mitoxantrone—sarcoma	0.00263	0.00263	CcSEcCtD
Verteporfin—Body temperature increased—Dactinomycin—sarcoma	0.00262	0.00262	CcSEcCtD
Verteporfin—Loss of consciousness—Etoposide—sarcoma	0.00258	0.00258	CcSEcCtD
Verteporfin—Dyspnoea—Mitoxantrone—sarcoma	0.00257	0.00257	CcSEcCtD
Verteporfin—Cough—Etoposide—sarcoma	0.00256	0.00256	CcSEcCtD
Verteporfin—Blood creatinine increased—Epirubicin—sarcoma	0.00256	0.00256	CcSEcCtD
Verteporfin—Gastrointestinal disorder—Vincristine—sarcoma	0.00255	0.00255	CcSEcCtD
Verteporfin—Hypertension—Etoposide—sarcoma	0.00254	0.00254	CcSEcCtD
Verteporfin—Constipation—Vincristine—sarcoma	0.00253	0.00253	CcSEcCtD
Verteporfin—Pain—Vincristine—sarcoma	0.00253	0.00253	CcSEcCtD
Verteporfin—Osteoarthritis—Doxorubicin—sarcoma	0.00253	0.00253	CcSEcCtD
Verteporfin—Diplopia—Doxorubicin—sarcoma	0.00253	0.00253	CcSEcCtD
Verteporfin—Liver function test abnormal—Epirubicin—sarcoma	0.00252	0.00252	CcSEcCtD
Verteporfin—Chest pain—Etoposide—sarcoma	0.0025	0.0025	CcSEcCtD
Verteporfin—Unspecified disorder of skin and subcutaneous tissue—Etoposide—sarcoma	0.00248	0.00248	CcSEcCtD
Verteporfin—Discomfort—Etoposide—sarcoma	0.00247	0.00247	CcSEcCtD
Verteporfin—Pain—Mitoxantrone—sarcoma	0.00246	0.00246	CcSEcCtD
Verteporfin—Constipation—Mitoxantrone—sarcoma	0.00246	0.00246	CcSEcCtD
Verteporfin—Hypersensitivity—Thiotepa—sarcoma	0.00246	0.00246	CcSEcCtD
Verteporfin—Hypersensitivity—Dactinomycin—sarcoma	0.00244	0.00244	CcSEcCtD
Verteporfin—Muscular weakness—Epirubicin—sarcoma	0.00241	0.00241	CcSEcCtD
Verteporfin—Asthenia—Thiotepa—sarcoma	0.00239	0.00239	CcSEcCtD
Verteporfin—Asthenia—Dactinomycin—sarcoma	0.00238	0.00238	CcSEcCtD
Verteporfin—Feeling abnormal—Mitoxantrone—sarcoma	0.00237	0.00237	CcSEcCtD
Verteporfin—Blood creatinine increased—Doxorubicin—sarcoma	0.00237	0.00237	CcSEcCtD
Verteporfin—Influenza—Epirubicin—sarcoma	0.00236	0.00236	CcSEcCtD
Verteporfin—Pruritus—Thiotepa—sarcoma	0.00236	0.00236	CcSEcCtD
Verteporfin—Body temperature increased—Vincristine—sarcoma	0.00234	0.00234	CcSEcCtD
Verteporfin—Liver function test abnormal—Doxorubicin—sarcoma	0.00234	0.00234	CcSEcCtD
Verteporfin—Skin disorder—Etoposide—sarcoma	0.00233	0.00233	CcSEcCtD
Verteporfin—Hyperhidrosis—Etoposide—sarcoma	0.00232	0.00232	CcSEcCtD
Verteporfin—Urticaria—Mitoxantrone—sarcoma	0.00229	0.00229	CcSEcCtD
Verteporfin—Body temperature increased—Mitoxantrone—sarcoma	0.00228	0.00228	CcSEcCtD
Verteporfin—Muscular weakness—Doxorubicin—sarcoma	0.00223	0.00223	CcSEcCtD
Verteporfin—Dizziness—Thiotepa—sarcoma	0.00221	0.00221	CcSEcCtD
Verteporfin—Influenza—Doxorubicin—sarcoma	0.00219	0.00219	CcSEcCtD
Verteporfin—Hypersensitivity—Vincristine—sarcoma	0.00218	0.00218	CcSEcCtD
Verteporfin—Photosensitivity reaction—Epirubicin—sarcoma	0.00216	0.00216	CcSEcCtD
Verteporfin—Dyspnoea—Etoposide—sarcoma	0.00214	0.00214	CcSEcCtD
Verteporfin—Hypersensitivity—Mitoxantrone—sarcoma	0.00212	0.00212	CcSEcCtD
Verteporfin—Asthenia—Vincristine—sarcoma	0.00212	0.00212	CcSEcCtD
Verteporfin—Pneumonia—Epirubicin—sarcoma	0.00212	0.00212	CcSEcCtD
Verteporfin—Rash—Thiotepa—sarcoma	0.0021	0.0021	CcSEcCtD
Verteporfin—Dermatitis—Thiotepa—sarcoma	0.0021	0.0021	CcSEcCtD
Verteporfin—Headache—Thiotepa—sarcoma	0.00209	0.00209	CcSEcCtD
Verteporfin—Rash—Dactinomycin—sarcoma	0.00209	0.00209	CcSEcCtD
Verteporfin—Gastrointestinal disorder—Etoposide—sarcoma	0.00207	0.00207	CcSEcCtD
Verteporfin—Asthenia—Mitoxantrone—sarcoma	0.00207	0.00207	CcSEcCtD
Verteporfin—Pain—Etoposide—sarcoma	0.00205	0.00205	CcSEcCtD
Verteporfin—Constipation—Etoposide—sarcoma	0.00205	0.00205	CcSEcCtD
Verteporfin—Conjunctivitis—Epirubicin—sarcoma	0.00205	0.00205	CcSEcCtD
Verteporfin—Sweating—Epirubicin—sarcoma	0.00202	0.00202	CcSEcCtD
Verteporfin—Photosensitivity reaction—Doxorubicin—sarcoma	0.002	0.002	CcSEcCtD
Verteporfin—Nausea—Thiotepa—sarcoma	0.00198	0.00198	CcSEcCtD
Verteporfin—Feeling abnormal—Etoposide—sarcoma	0.00198	0.00198	CcSEcCtD
Verteporfin—Nausea—Dactinomycin—sarcoma	0.00197	0.00197	CcSEcCtD
Verteporfin—Pneumonia—Doxorubicin—sarcoma	0.00196	0.00196	CcSEcCtD
Verteporfin—Dizziness—Vincristine—sarcoma	0.00196	0.00196	CcSEcCtD
Verteporfin—Urticaria—Etoposide—sarcoma	0.0019	0.0019	CcSEcCtD
Verteporfin—Haemoglobin—Epirubicin—sarcoma	0.0019	0.0019	CcSEcCtD
Verteporfin—Body temperature increased—Etoposide—sarcoma	0.00189	0.00189	CcSEcCtD
Verteporfin—Conjunctivitis—Doxorubicin—sarcoma	0.00189	0.00189	CcSEcCtD
Verteporfin—Haemorrhage—Epirubicin—sarcoma	0.00189	0.00189	CcSEcCtD
Verteporfin—Hypoaesthesia—Epirubicin—sarcoma	0.00188	0.00188	CcSEcCtD
Verteporfin—Pharyngitis—Epirubicin—sarcoma	0.00188	0.00188	CcSEcCtD
Verteporfin—Sweating—Doxorubicin—sarcoma	0.00187	0.00187	CcSEcCtD
Verteporfin—Rash—Vincristine—sarcoma	0.00187	0.00187	CcSEcCtD
Verteporfin—Dermatitis—Vincristine—sarcoma	0.00186	0.00186	CcSEcCtD
Verteporfin—Headache—Vincristine—sarcoma	0.00185	0.00185	CcSEcCtD
Verteporfin—Visual impairment—Epirubicin—sarcoma	0.00182	0.00182	CcSEcCtD
Verteporfin—Rash—Mitoxantrone—sarcoma	0.00182	0.00182	CcSEcCtD
Verteporfin—Dermatitis—Mitoxantrone—sarcoma	0.00182	0.00182	CcSEcCtD
Verteporfin—Headache—Mitoxantrone—sarcoma	0.00181	0.00181	CcSEcCtD
Verteporfin—Eye disorder—Epirubicin—sarcoma	0.00177	0.00177	CcSEcCtD
Verteporfin—Hypersensitivity—Etoposide—sarcoma	0.00177	0.00177	CcSEcCtD
Verteporfin—Haemoglobin—Doxorubicin—sarcoma	0.00176	0.00176	CcSEcCtD
Verteporfin—Nausea—Vincristine—sarcoma	0.00176	0.00176	CcSEcCtD
Verteporfin—Flushing—Epirubicin—sarcoma	0.00176	0.00176	CcSEcCtD
Verteporfin—Cardiac disorder—Epirubicin—sarcoma	0.00176	0.00176	CcSEcCtD
Verteporfin—Haemorrhage—Doxorubicin—sarcoma	0.00175	0.00175	CcSEcCtD
Verteporfin—Hypoaesthesia—Doxorubicin—sarcoma	0.00174	0.00174	CcSEcCtD
Verteporfin—Pharyngitis—Doxorubicin—sarcoma	0.00174	0.00174	CcSEcCtD
Verteporfin—Asthenia—Etoposide—sarcoma	0.00172	0.00172	CcSEcCtD
Verteporfin—Angiopathy—Epirubicin—sarcoma	0.00172	0.00172	CcSEcCtD
Verteporfin—Nausea—Mitoxantrone—sarcoma	0.00171	0.00171	CcSEcCtD
Verteporfin—Immune system disorder—Epirubicin—sarcoma	0.00171	0.00171	CcSEcCtD
Verteporfin—Pruritus—Etoposide—sarcoma	0.0017	0.0017	CcSEcCtD
Verteporfin—Visual impairment—Doxorubicin—sarcoma	0.00169	0.00169	CcSEcCtD
Verteporfin—Malnutrition—Epirubicin—sarcoma	0.00165	0.00165	CcSEcCtD
Verteporfin—Eye disorder—Doxorubicin—sarcoma	0.00164	0.00164	CcSEcCtD
Verteporfin—Flushing—Doxorubicin—sarcoma	0.00162	0.00162	CcSEcCtD
Verteporfin—Cardiac disorder—Doxorubicin—sarcoma	0.00162	0.00162	CcSEcCtD
Verteporfin—Back pain—Epirubicin—sarcoma	0.00159	0.00159	CcSEcCtD
Verteporfin—Angiopathy—Doxorubicin—sarcoma	0.00159	0.00159	CcSEcCtD
Verteporfin—Dizziness—Etoposide—sarcoma	0.00159	0.00159	CcSEcCtD
Verteporfin—Immune system disorder—Doxorubicin—sarcoma	0.00158	0.00158	CcSEcCtD
Verteporfin—Vision blurred—Epirubicin—sarcoma	0.00155	0.00155	CcSEcCtD
Verteporfin—Ill-defined disorder—Epirubicin—sarcoma	0.00153	0.00153	CcSEcCtD
Verteporfin—Malnutrition—Doxorubicin—sarcoma	0.00152	0.00152	CcSEcCtD
Verteporfin—Anaemia—Epirubicin—sarcoma	0.00152	0.00152	CcSEcCtD
Verteporfin—Rash—Etoposide—sarcoma	0.00151	0.00151	CcSEcCtD
Verteporfin—Dermatitis—Etoposide—sarcoma	0.00151	0.00151	CcSEcCtD
Verteporfin—Headache—Etoposide—sarcoma	0.0015	0.0015	CcSEcCtD
Verteporfin—Malaise—Epirubicin—sarcoma	0.00148	0.00148	CcSEcCtD
Verteporfin—Vertigo—Epirubicin—sarcoma	0.00148	0.00148	CcSEcCtD
Verteporfin—Syncope—Epirubicin—sarcoma	0.00148	0.00148	CcSEcCtD
Verteporfin—Back pain—Doxorubicin—sarcoma	0.00147	0.00147	CcSEcCtD
Verteporfin—Loss of consciousness—Epirubicin—sarcoma	0.00145	0.00145	CcSEcCtD
Verteporfin—Cough—Epirubicin—sarcoma	0.00144	0.00144	CcSEcCtD
Verteporfin—Vision blurred—Doxorubicin—sarcoma	0.00144	0.00144	CcSEcCtD
Verteporfin—Nausea—Etoposide—sarcoma	0.00142	0.00142	CcSEcCtD
Verteporfin—Hypertension—Epirubicin—sarcoma	0.00142	0.00142	CcSEcCtD
Verteporfin—Ill-defined disorder—Doxorubicin—sarcoma	0.00141	0.00141	CcSEcCtD
Verteporfin—Anaemia—Doxorubicin—sarcoma	0.00141	0.00141	CcSEcCtD
Verteporfin—Chest pain—Epirubicin—sarcoma	0.0014	0.0014	CcSEcCtD
Verteporfin—Arthralgia—Epirubicin—sarcoma	0.0014	0.0014	CcSEcCtD
Verteporfin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—sarcoma	0.00139	0.00139	CcSEcCtD
Verteporfin—Discomfort—Epirubicin—sarcoma	0.00138	0.00138	CcSEcCtD
Verteporfin—Malaise—Doxorubicin—sarcoma	0.00137	0.00137	CcSEcCtD
Verteporfin—Vertigo—Doxorubicin—sarcoma	0.00137	0.00137	CcSEcCtD
Verteporfin—Syncope—Doxorubicin—sarcoma	0.00137	0.00137	CcSEcCtD
Verteporfin—Oedema—Epirubicin—sarcoma	0.00134	0.00134	CcSEcCtD
Verteporfin—Loss of consciousness—Doxorubicin—sarcoma	0.00134	0.00134	CcSEcCtD
Verteporfin—Cough—Doxorubicin—sarcoma	0.00133	0.00133	CcSEcCtD
Verteporfin—Shock—Epirubicin—sarcoma	0.00132	0.00132	CcSEcCtD
Verteporfin—Nervous system disorder—Epirubicin—sarcoma	0.00132	0.00132	CcSEcCtD
Verteporfin—Hypertension—Doxorubicin—sarcoma	0.00132	0.00132	CcSEcCtD
Verteporfin—Skin disorder—Epirubicin—sarcoma	0.00131	0.00131	CcSEcCtD
Verteporfin—Hyperhidrosis—Epirubicin—sarcoma	0.0013	0.0013	CcSEcCtD
Verteporfin—Arthralgia—Doxorubicin—sarcoma	0.0013	0.0013	CcSEcCtD
Verteporfin—Chest pain—Doxorubicin—sarcoma	0.0013	0.0013	CcSEcCtD
Verteporfin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—sarcoma	0.00129	0.00129	CcSEcCtD
Verteporfin—Discomfort—Doxorubicin—sarcoma	0.00128	0.00128	CcSEcCtD
Verteporfin—Oedema—Doxorubicin—sarcoma	0.00124	0.00124	CcSEcCtD
Verteporfin—Musculoskeletal discomfort—Epirubicin—sarcoma	0.00122	0.00122	CcSEcCtD
Verteporfin—Shock—Doxorubicin—sarcoma	0.00122	0.00122	CcSEcCtD
Verteporfin—Nervous system disorder—Doxorubicin—sarcoma	0.00122	0.00122	CcSEcCtD
Verteporfin—Skin disorder—Doxorubicin—sarcoma	0.00121	0.00121	CcSEcCtD
Verteporfin—Hyperhidrosis—Doxorubicin—sarcoma	0.0012	0.0012	CcSEcCtD
Verteporfin—Dyspnoea—Epirubicin—sarcoma	0.0012	0.0012	CcSEcCtD
Verteporfin—Gastrointestinal disorder—Epirubicin—sarcoma	0.00116	0.00116	CcSEcCtD
Verteporfin—Constipation—Epirubicin—sarcoma	0.00115	0.00115	CcSEcCtD
Verteporfin—Pain—Epirubicin—sarcoma	0.00115	0.00115	CcSEcCtD
Verteporfin—Musculoskeletal discomfort—Doxorubicin—sarcoma	0.00113	0.00113	CcSEcCtD
Verteporfin—Dyspnoea—Doxorubicin—sarcoma	0.00111	0.00111	CcSEcCtD
Verteporfin—Feeling abnormal—Epirubicin—sarcoma	0.00111	0.00111	CcSEcCtD
Verteporfin—Gastrointestinal disorder—Doxorubicin—sarcoma	0.00107	0.00107	CcSEcCtD
Verteporfin—Urticaria—Epirubicin—sarcoma	0.00107	0.00107	CcSEcCtD
Verteporfin—Pain—Doxorubicin—sarcoma	0.00106	0.00106	CcSEcCtD
Verteporfin—Constipation—Doxorubicin—sarcoma	0.00106	0.00106	CcSEcCtD
Verteporfin—Body temperature increased—Epirubicin—sarcoma	0.00106	0.00106	CcSEcCtD
Verteporfin—Feeling abnormal—Doxorubicin—sarcoma	0.00102	0.00102	CcSEcCtD
Verteporfin—Hypersensitivity—Epirubicin—sarcoma	0.00099	0.00099	CcSEcCtD
Verteporfin—Urticaria—Doxorubicin—sarcoma	0.000988	0.000988	CcSEcCtD
Verteporfin—Body temperature increased—Doxorubicin—sarcoma	0.000983	0.000983	CcSEcCtD
Verteporfin—Asthenia—Epirubicin—sarcoma	0.000964	0.000964	CcSEcCtD
Verteporfin—Pruritus—Epirubicin—sarcoma	0.000951	0.000951	CcSEcCtD
Verteporfin—Hypersensitivity—Doxorubicin—sarcoma	0.000916	0.000916	CcSEcCtD
Verteporfin—Asthenia—Doxorubicin—sarcoma	0.000892	0.000892	CcSEcCtD
Verteporfin—Dizziness—Epirubicin—sarcoma	0.000889	0.000889	CcSEcCtD
Verteporfin—Pruritus—Doxorubicin—sarcoma	0.00088	0.00088	CcSEcCtD
Verteporfin—Rash—Epirubicin—sarcoma	0.000847	0.000847	CcSEcCtD
Verteporfin—Dermatitis—Epirubicin—sarcoma	0.000846	0.000846	CcSEcCtD
Verteporfin—Headache—Epirubicin—sarcoma	0.000842	0.000842	CcSEcCtD
Verteporfin—Dizziness—Doxorubicin—sarcoma	0.000822	0.000822	CcSEcCtD
Verteporfin—Nausea—Epirubicin—sarcoma	0.000798	0.000798	CcSEcCtD
Verteporfin—Rash—Doxorubicin—sarcoma	0.000784	0.000784	CcSEcCtD
Verteporfin—Dermatitis—Doxorubicin—sarcoma	0.000783	0.000783	CcSEcCtD
Verteporfin—Headache—Doxorubicin—sarcoma	0.000779	0.000779	CcSEcCtD
Verteporfin—Nausea—Doxorubicin—sarcoma	0.000738	0.000738	CcSEcCtD
